Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

8.53USD
17 Apr 2015
Change (% chg)

$1.43 (+20.14%)
Prev Close
$7.10
Open
$7.02
Day's High
$9.16
Day's Low
$7.00
Volume
351,726
Avg. Vol
58,197
52-wk High
$9.16
52-wk Low
$2.98

TROV.OQ

Chart for TROV.OQ

About

Trovagene, Inc. (TrovaGene) is a development-stage molecular diagnostic company that focuses on the development and commercialization of urine-based molecular diagnostic technology for use in disease detection and monitoring across a variety of medical disciplines. The Company’s internal focus is to leverage its urine-based... (more)

Overall

Beta: -0.71
Market Cap(Mil.): $205.78
Shares Outstanding(Mil.): 24.12
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 25.51 41.17
EPS (TTM): -0.76 -- --
ROI: -57.82 7.15 16.08
ROE: -99.85 21.29 16.92
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks